Estech sees first patients in staged hybrid ablation study

The first three patients have been enrolled in the European HISTORIC-AF staged hybrid ablation study, Estech announced Monday afternoon. Ten centers will participate in the study, which is expected to enroll more than 100 persistent and long-standing persistent atrial fibrillation patients in Italy, Germany, the U.K., France and Poland. Estech release

Suggested Articles

The agency also gave the company’s diagnostic, run on the high-throughput Panther Fusion laboratory platform, a green light for pooled testing.

Smith & Nephew has signed up to acquire Integra LifeSciences’ orthopedics business focused on the growing upper and lower extremity markets.

The company describes the continuous glucose monitor as the world’s smallest and thinnest diabetes sensor, with a disc about the size of two pennies.